Opportunity overview
Contract of 5 years, with an option to extend maintenance and consumables beyond this period for a further period of up to 10 years or the end of useful life of the equipment
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Buchi UK Ltd
Match pending…
- Contract value
- £200k
- Awarded
- Not supplied
- Contract signed
- 1 May 2025
- Award ID
- 024424-2025-QUB/2642/25-1
- Status
- active
- Location
- Suffolk, UKH14, United Kingdom
Classification
- CPV33100000 — Medical equipments
- CPV38000000 — Laboratory, optical and precision equipments (excl. glasses)
- CPV38432200 — Chromatographs
- CPV38434540 — Biomedical equipment
Lots
- The Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT) is an industry-focused partnership of Life and Health Science (LHS) companies and Academia, aligned to NI Health and Economy strategies. By addressing critical commercial gaps, the Consortium's aim is to transform the productivity of each Commercial Partner and the broader LHS sector in NI. NIPBT will deploy the grant funding to collaboratively develop R&D capabilities that industry partners require. Queen’s is leading and hosting this research hub, as such is tasked with procuring and installing supercritical fluid preparative system within the Health Sciences Building, Queen’s University Belfast, 97 Lisburn Road, Belfast, BT9 7 AE. Queen’s University of Belfast wishes to procure a supercritical fluid preparative system that can support analytical method development and preparative LC. The system will be used for the purification of synthetic small molecule compound libraries.Value not stated